ELAN
Elanco Animal Health Incorporated
Drug Manufacturers - Specialty & Generic · Healthcare · United States
23.24
close · 2026-10-29
value
45
cheaper than peers45
quality
54
stronger fundamentals54
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.76× | 73 |
| price to sales | 2.41× | 55 |
| EV to EBITDA | 16.83× | 39 |
| forward P/E | 18.26× | 27 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 10.2% | 64 |
| operating margin | 8.6% | 56 |
| debt to equity | 66.2% | 53 |
| return on equity | -3.8% | 43 |
4 of 4 measures available
Facts
| market cap | $12B |
| free cash flow | $692.1M |
| employees | 9,400 |
| first trade | 2018-09-20 |
| next earnings | 2026-11-06 |
| fundamentals updated | 2026-08-06 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.47 | 0.68 | -2.50 | -0.15 |
| free cash flow | $284.0M | $394.0M | $131.0M | $268.0M |
| net income | -$232.0M | $338.0M | -$1.23B | -$78.0M |
| revenue | $4.71B | $4.44B | $4.42B | $4.41B |
| unusual items | -$237.0M | $490.0M | -$1.17B | -$183.0M |